Acceder

Análisis técnico y gráfico histórico de Horizon Pharma

Análisis fundamental y estadísticas clave de Horizon Pharma

Ficha de Horizon Pharma (HZNP)

Ticker HZNP
ISIN IE00BQPVQZ61
Sector Atención sanitaria
Mercado NASDAQ

Análisis financiero de Horizon Pharma

Briefing Valoración Rentabilidad Métricas por acción Deuda Liquidez

Resumen financiero e información corporativa de Horizon Pharma

Invertir en Horizon Pharma en 2026: Preguntas frecuentes

¿Qué es Horizon Pharma?

Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines in the areas of rare diseases, gout, ophthalmology, and inflammation. It markets TEPEZZA (teprotumumab-trbw) for intravenous infusion; KRYSTEXXA (pegl...

¿En qué sector opera Horizon Pharma?

Horizon Pharma opera en el sector Healthcare, industria Drug Manufacturers - General.